Rosemarinic Acid-Induced Destabilization of Aβ Peptides: Insights from Molecular Dynamics Simulations

Rosemarinic Acid-Induced Destabilization of Aβ Peptides: Insights from Molecular Dynamics Simulations

Alzheimer’s disease (AD) is a neurodegenerative disorder marked by the progressive accumulation of amyloid-β (Aβ) plaques and tau protein tangles in the brain. These pathological aggregates interfere with neuronal function, leading to the disruption of cognitive processes, particularly memory. The d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liang Zhao, Weiye Jiang, Zehui Zhu, Fei Pan, Xin Xing, Feng Zhou, Lei Zhao
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Foods
Subjects:	Alzheimer’s disease rosmarinic acid amyloid-β peptide molecular dynamics free energy landscape Poisson–Boltzmann surface area mechanics
Online Access:	https://www.mdpi.com/2304-8158/13/24/4170
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
by: Aixin Ni, et al.
Published: (2023-09-01)

Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment
by: Sajjad Molavipordanjani, et al.
Published: (2023-11-01)

Aβ aggregation inhibition via peptide-conjugated gold nanoclusters: Mechanistic insights and therapeutic potential
by: Ye-Cheng Wang, et al.
Published: (2025-06-01)

Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
by: Carlos Gutierrez-Merino
Published: (2025-02-01)

New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease
by: Aneta Houfková, et al.
Published: (2025-07-01)

S100A8 Interaction with Amyloid-β Peptide Suppresses Its Fibrillation
by: Ekaterina Litus, et al.
Published: (2024-04-01)

The Alkaloid Gelsemine Reduces Aβ Peptide Toxicity by Targeting Transglutaminase Type 2 Enzyme
by: Jessica Panes-Fernández, et al.
Published: (2025-05-01)

Reevaluating the role of amyloid β-peptides in Alzheimer’s disease: from pathogenic agents to protective chelation mechanisms
by: Franco Cavaleri
Published: (2025-03-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Generation and deposition of Aβ43 by the virtually inactive presenilin‐1 L435F mutant contradicts the presenilin loss‐of‐function hypothesis of Alzheimer's disease
by: Benedikt Kretner, et al.
Published: (2016-03-01)

Specific Binding of Alzheimer’s Abeta Peptide Fibrils to Single Walled Carbon Nanotubes
by: Steingrimur Stefansson, et al.
Published: (2012-10-01)

Decrease in p3‐Alcβ37 and p3‐Alcβ40, products of Alcadein β generated by γ‐secretase cleavages, in aged monkeys and patients with Alzheimer's disease
by: Saori Hata, et al.
Published: (2019-01-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

Antioxidant, anti-acetylcholinesterase, and anti-amyloid-β peptide aggregations of hispolon and its analogs in vitro and improved learning and memory functions in scopolamine-induced ICR mice
by: Chang-Hang Yang, et al.
Published: (2024-12-01)

Molecular Dynamics of Apolipoprotein Genotypes APOE4 and SNARE Family Proteins and Their Impact on Alzheimer’s Disease
by: Yuqing Wang, et al.
Published: (2025-02-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Disruption of hnRNP A2-mediated RNA dynamics by amyloid-β drives MBP increase in Alzheimer’s disease
by: Adhara Gaminde-Blasco, et al.
Published: (2025-08-01)

Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
by: Kai Schlepckow, et al.
Published: (2020-03-01)

Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
by: Hongtao Du, et al.
Published: (2025-01-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ
by: Mengxun Luo, et al.
Published: (2025-04-01)

The Effect of Polyethylene Terephthalate Nanoplastics on Amyloid-β Peptide Fibrillation
by: Narmin Bashirova, et al.
Published: (2025-03-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
by: Akihiro Kitani, et al.
Published: (2025-04-01)

FLIM-Phasor Analysis (FLIM-ϕ) of Aβ-Induced Membrane Order Alterations: Towards a Cell-Based Biosensor for Early Alzheimer’s Disease Diagnosis
by: Antonella Battisti, et al.
Published: (2025-02-01)

The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy
by: Yuichi Kawai, et al.
Published: (2025-07-01)

Docosahexaenoic acid-acylated astaxanthin monoester enhances microglial autophagy for ameliorating amyloid-β load and cognitive deficits in models of Alzheimer’s disease
by: Xiaoxu Wang, et al.
Published: (2025-06-01)

Distinct Chemical Determinants are Essential for Achieving Ligands for Superior Optical Detection of Specific Amyloid‐β Deposits in Alzheimer's Disease
by: Dr. Xiongyu Wu, et al.
Published: (2024-12-01)

Sesamol Inhibits Aβ1-42-Induced Ferroptosis by Regulating the SLC7A11/GPX4/ACSL4 Axis in PC12 Cells
by: ZHAO Peijun, WANG Tianlin, XIE Shanshan, SONG Lianjun, HUANG Xianqing, LI Tiange
Published: (2025-05-01)

Middle-aged dogs with low and high Aβ CSF concentrations show differences in energy and stress related metabolic profiles in CSF
by: Herman Borghys, et al.
Published: (2024-10-01)

Amyloid β perturbs elevated heme flux induced with neuronal development
by: Chantal Vidal, et al.
Published: (2019-01-01)

Protein to biomaterials: Unraveling the antiviral and proangiogenic activities of Ac-Tβ1-17 peptide, a thymosin β4 metabolite, and its implications in peptide-scaffold preparation
by: Khandoker Asiqur Rahaman, et al.
Published: (2025-07-01)

An improved immunoassay detects Aβ oligomers in human biofluids: their CSF levels rise with tau and phosphotau levels
by: Ting Yang, et al.
Published: (2025-07-01)

Distribution of β-amyloid and pTau in brain cortex depending on age and mental state
by: Alexandra V. Sentyabreva, et al.
Published: (2024-12-01)

A microbead-enhanced electrochemical platform for β-amyloid peptide (1–42) detection
by: Claudia do Amaral Razzino, et al.
Published: (2024-12-01)

miR‐32533 Reduces Cognitive Impairment and Amyloid‐β Overload by Targeting CREB5‐Mediated Signaling Pathways in Alzheimer's Disease
by: Li Zeng, et al.
Published: (2025-03-01)

Pathological axonal enlargement in connection with amyloidosis, lysosome destabilization, and bleeding is a major defect in Alzheimer’s disease
by: Hualin Fu, et al.
Published: (2026-02-01)

Aβ42 induces stress granule formation via PACT/PKR pathway
by: Vijay Sankar Ramasamy, et al.
Published: (2025-02-01)

Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis
by: Fang Li, et al.
Published: (2024-10-01)